Real-time Estimate
Cboe BZX
09:40:06 2024-05-24 am EDT
|
5-day change
|
1st Jan Change
|
27.92
USD
|
+1.18%
|
|
+4.59%
|
+74.84%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
188.6
|
448.4
|
1,647
|
780.2
|
1,204
|
2,101
|
-
|
-
|
Enterprise Value (EV)
1 |
188.1
|
435.6
|
1,647
|
780.2
|
1,180
|
2,140
|
2,429
|
2,532
|
P/E ratio
|
-12.9
x
|
-20.1
x
|
-40.8
x
|
-5.61
x
|
-23.9
x
|
360
x
|
42.1
x
|
24
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.35
x
|
4.47
x
|
13.5
x
|
4.33
x
|
5.04
x
|
5.32
x
|
3.74
x
|
2.95
x
|
EV / Revenue
|
1.35
x
|
4.34
x
|
13.5
x
|
4.33
x
|
4.94
x
|
5.41
x
|
4.32
x
|
3.55
x
|
EV / EBITDA
|
-1,075
x
|
-68.4
x
|
-63.4
x
|
-12.9
x
|
-51.4
x
|
35.4
x
|
19.9
x
|
14.1
x
|
EV / FCF
|
-59.4
x
|
-32.7
x
|
-50.8
x
|
-2.86
x
|
-5.41
x
|
-40.3
x
|
-12.2
x
|
156
x
|
FCF Yield
|
-1.68%
|
-3.06%
|
-1.97%
|
-34.9%
|
-18.5%
|
-2.48%
|
-8.21%
|
0.64%
|
Price to Book
|
3.2
x
|
6.84
x
|
11.8
x
|
1.05
x
|
2.47
x
|
4.15
x
|
3.73
x
|
3.45
x
|
Nbr of stocks (in thousands)
|
24,300
|
26,868
|
33,079
|
66,173
|
76,318
|
76,161
|
-
|
-
|
Reference price
2 |
7.760
|
16.69
|
49.79
|
11.79
|
15.78
|
27.59
|
27.59
|
27.59
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/15/23
|
2/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
139.4
|
100.3
|
121.6
|
180.4
|
238.7
|
395.3
|
561.6
|
712.3
|
EBITDA
1 |
-0.175
|
-6.367
|
-25.98
|
-60.64
|
-22.93
|
60.37
|
121.9
|
179
|
EBIT
1 |
-14.16
|
-21.57
|
-40.6
|
-79.24
|
-49.2
|
16.4
|
69.49
|
122.3
|
Operating Margin
|
-10.16%
|
-21.51%
|
-33.38%
|
-43.94%
|
-20.61%
|
4.15%
|
12.37%
|
17.17%
|
Earnings before Tax (EBT)
1 |
-14.56
|
-21.81
|
-37.09
|
-82.74
|
-45.81
|
7.195
|
53.61
|
99.44
|
Net income
1 |
-14.56
|
-21.81
|
-37.09
|
-82.74
|
-45.81
|
5.736
|
50.52
|
89.99
|
Net margin
|
-10.45%
|
-21.75%
|
-30.5%
|
-45.87%
|
-19.19%
|
1.45%
|
8.99%
|
12.63%
|
EPS
2 |
-0.6000
|
-0.8300
|
-1.220
|
-2.100
|
-0.6600
|
0.0767
|
0.6556
|
1.148
|
Free Cash Flow
1 |
-3.166
|
-13.34
|
-32.41
|
-272.4
|
-218.1
|
-53.09
|
-199.5
|
16.22
|
FCF margin
|
-2.27%
|
-13.3%
|
-26.64%
|
-151.01%
|
-91.35%
|
-13.43%
|
-35.52%
|
2.28%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
9.06%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
18.02%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/15/23
|
2/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
31.48
|
38.41
|
45.64
|
36.71
|
59.61
|
45.59
|
48.16
|
60.76
|
84.22
|
94.5
|
99.32
|
102.6
|
98.91
|
118.2
|
131.6
|
EBITDA
1 |
-12.15
|
-14.67
|
-18.32
|
-23.19
|
-4.464
|
-13.94
|
-10.83
|
-7.295
|
9.132
|
12.93
|
14.94
|
16.41
|
15.18
|
26.08
|
32.21
|
EBIT
1 |
-16.31
|
-18.62
|
-22.65
|
-28.31
|
-9.666
|
-18.91
|
-17.04
|
-14.63
|
1.383
|
5.138
|
4.732
|
4.672
|
2.836
|
10.8
|
14.6
|
Operating Margin
|
-51.83%
|
-48.49%
|
-49.62%
|
-77.12%
|
-16.22%
|
-41.48%
|
-35.39%
|
-24.09%
|
1.64%
|
5.44%
|
4.76%
|
4.55%
|
2.87%
|
9.14%
|
11.1%
|
Earnings before Tax (EBT)
1 |
-16.35
|
-19.48
|
-24.05
|
-29.6
|
-9.609
|
-16.8
|
-15.42
|
-13.07
|
-0.519
|
-1.079
|
3.144
|
3.074
|
0.7368
|
8.1
|
11.8
|
Net income
1 |
-16.35
|
-19.48
|
-24.05
|
-29.6
|
-9.609
|
-16.8
|
-15.42
|
-13.07
|
-0.519
|
-1.835
|
3.223
|
3.271
|
0.6884
|
8.686
|
13.21
|
Net margin
|
-51.96%
|
-50.73%
|
-52.7%
|
-80.63%
|
-16.12%
|
-36.84%
|
-32.03%
|
-21.52%
|
-0.62%
|
-1.94%
|
3.25%
|
3.19%
|
0.7%
|
7.35%
|
10.04%
|
EPS
2 |
-0.5000
|
-0.5900
|
-0.6800
|
-0.7500
|
-0.2000
|
-0.2400
|
-0.2200
|
-0.1900
|
-0.0100
|
-0.0200
|
0.0433
|
0.0422
|
0.008890
|
0.0900
|
0.1450
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/15/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/12/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
38.7
|
328
|
431
|
Net Cash position
1 |
0.51
|
12.8
|
-
|
-
|
24.7
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.641
x
|
2.688
x
|
2.406
x
|
Free Cash Flow
1 |
-3.17
|
-13.3
|
-32.4
|
-272
|
-218
|
-53.1
|
-200
|
16.2
|
ROE (net income / shareholders' equity)
|
-22.5%
|
-34.4%
|
-21.1%
|
-28.9%
|
-9.79%
|
3.35%
|
9.1%
|
10.2%
|
ROA (Net income/ Total Assets)
|
-14.4%
|
-21.7%
|
-29.1%
|
-19.9%
|
-6.8%
|
4.45%
|
9.1%
|
5.4%
|
Assets
1 |
101.3
|
100.5
|
127.4
|
414.8
|
673.2
|
128.9
|
555.1
|
1,666
|
Book Value Per Share
2 |
2.430
|
2.440
|
4.220
|
11.30
|
6.380
|
6.650
|
7.410
|
8.000
|
Cash Flow per Share
2 |
-0.0400
|
-0.3800
|
-0.6100
|
-2.400
|
-0.6100
|
-0.2100
|
1.170
|
1.420
|
Capex
1 |
2.11
|
3.42
|
13.8
|
178
|
175
|
73.2
|
447
|
167
|
Capex / Sales
|
1.52%
|
3.41%
|
11.33%
|
98.67%
|
73.5%
|
18.5%
|
79.55%
|
23.45%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/15/23
|
2/12/24
|
-
|
-
|
-
|
Last Close Price
27.59
USD Average target price
27.5
USD Spread / Average Target -0.33% Consensus |
1st Jan change
|
Capi.
|
---|
| +74.84% | 2.1B | | +17.53% | 66.57B | | +2.81% | 49.81B | | +21.61% | 42.77B | | +22.79% | 26.3B | | +10.06% | 19.26B | | -2.43% | 16.56B | | +5.98% | 15.96B | | -14.90% | 14.45B | | -27.16% | 14.82B |
Other Specialty Chemicals
|